0001415889-13-002588.txt : 20131217 0001415889-13-002588.hdr.sgml : 20131217 20131217171036 ACCESSION NUMBER: 0001415889-13-002588 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20131217 DATE AS OF CHANGE: 20131217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Echo Therapeutics, Inc. CENTRAL INDEX KEY: 0001031927 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411649949 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-192630 FILM NUMBER: 131282946 BUSINESS ADDRESS: STREET 1: 8 PENN CENTER STREET 2: 1628 JFK BLVD, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 215-717-4100 MAIL ADDRESS: STREET 1: 8 PENN CENTER STREET 2: 1628 JFK BLVD, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020702 FORMER COMPANY: FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/ DATE OF NAME CHANGE: 20020701 FORMER COMPANY: FORMER CONFORMED NAME: SONTRA MEDICAL CORP DATE OF NAME CHANGE: 20020701 RW 1 ecteformrwdec132013.htm ecteformrwdec132013.htm
ECHO THERAPEUTICS, INC.
8 Penn Center
1628 JFK Blvd., Suite 300
Philadelphia, PA 19103
 
December 17, 2013
 
VIA EDGAR
 
Securities and Exchange Commission
Division of Corporate Finance
100 F Street N.E.
Washington, D.C. 20549

Re:           Echo Therapeutics, Inc.
 Registration Statement on Form S-1 (Registration No. 333-192630)

 
Ladies and Gentlemen:
 
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), Echo Therapeutics, Inc. (the “Company”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of its Registration Statement on Form S-1 (File No. 333-192630), together with all exhibits thereto, filed on December 2, 2013 ( the “Registration Statement”).
 
The Company is seeking withdrawal of the Registration Statement in order to proceed with the Securities Purchase Agreement by and among the Company, Medical Technologies Innovation Asia, Ltd and Beijing Sino Tau Shang Pin Tech and Development Corp, and the Securities Purchase Agreement by and among the Company, Platinum Partners Value Arbitrage L.P and Platinum Partners Liquid Opportunity Master Fund L.P., each dated as of December 10, 2013 (collectively, the “Agreements”). Under Section 5.4 of the Agreements, the Company is required to withdraw the Registration Statement. The Company hereby confirms that no securities have been or will be sold pursuant to the Registration Statement.
 
The Company requests that, in accordance with Rule 457(p) under the Securities Act, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.
 
Please send copies of the written order granting withdrawal of the Registration Statement to Robert F. Doman, Executive Chairman and Interim Chief Executive Officer at the above-mentioned address, facsimile number (215) 717-4109, with a copy to Joanne R. Soslow, Morgan, Lewis & Bockius LLP, 1701 Market Street, Philadelphia, PA 19103, facsimile number (215) 963-5001.
 
If you have any questions with respect to this matter, please contact Joanne R. Soslow of Morgan, Lewis & Bockius LLP at (215) 963-5262.

Sincerely,
ECHO THERAPEUTICS, INC.
   
   
/s/ Robert F. Doman
   
Robert F. Doman
Executive Chairman and
Interim Chief Executive Officer